Skip to content
WeighLab

Allara Health vs WeightCare

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Allara Health

Provider comparison

Insured women who want hormonal-health specialists to manage a GLP-1 prescription, rather than shoppers pricing the drug alone.

Semaglutide / month
$149/moPlus a separate fee, brand-name
Tirzepatide / month
Not disclosed
Index 72/100 · Grade CChecked October 2026

WeightCare

Provider comparison

Shoppers who want a no-commitment monthly plan that covers every dose, with the option to lock in a much lower rate on a 12-month plan.

Semaglutide / month
$399/moAll doses, monthly plan, compounded; $249/mo on a 3-month plan, $215/mo on 6 months, $139/mo on 12 months
Tirzepatide / month
$499/moAll doses, monthly plan, compounded; $216/mo on a 12-month plan at any dose; the 3- and 6-month plans, $299/mo and $275/mo, stop at 7.5 mg
Index 72/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 72/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Allara Health
45 states + DC
WeightCare
46 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Allara Health

WeightCare

Semaglutide / month
Allara Health: $149/moPlus a separate fee, brand-name
WeightCare: $399/moAll doses, monthly plan, compounded; $249/mo on a 3-month plan, $215/mo on 6 months, $139/mo on 12 months
Tirzepatide / month
Allara Health: Not disclosed
WeightCare: $499/moAll doses, monthly plan, compounded; $216/mo on a 12-month plan at any dose; the 3- and 6-month plans, $299/mo and $275/mo, stop at 7.5 mg
Semaglutide / year (modeled)
Allara Health: $1,788
WeightCare: $4,788
Tirzepatide / year (modeled)
Allara Health: —
WeightCare: $5,988
State availability
Allara Health: 45 states + DC
WeightCare: 46 states
Oral / sublingual option listed
Allara Health: Yes
WeightCare: Not listed
Brand-name access listed
Allara Health: Yes
WeightCare: Not confirmed
Provider facts checked
Allara Health: October 2026
WeightCare: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Allara Health

Insured women who want hormonal-health specialists to manage a GLP-1 prescription, rather than shoppers pricing the drug alone.

Reasons to consider it

  • In-network with major insurers (Aetna, Blue Cross Blue Shield/Anthem/Carefirst, Cigna, United Healthcare/Oxford/UMR, GEHA), which can make branded GLP-1s cheaper than any cash-pay compounded option for covered patients
  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) rather than unapproved compounded preparations
  • Board-certified OB-GYNs, endocrinologists, and Registered Dietitians on a women's-health-specialized platform

What to weigh up

  • The only GLP-1 figure on the site is a 'starting at $77 per 50 days' card that names no drug or dose; the $149/mo is the care membership, and the medication cost depends on your insurance
  • Not a general low-cost GLP-1 shopping option — the platform is built around women's hormonal/PCOS specialty care, with GLP-1 as one treatment among many
  • A credit or debit card must be kept on file for automatic monthly membership billing

WeightCare

Shoppers who want a no-commitment monthly plan that covers every dose, with the option to lock in a much lower rate on a 12-month plan.

Reasons to consider it

  • True month-to-month plans with no commitment, covering every dose of both drugs
  • 12-month plans bring the price down to $139/mo for semaglutide and $216/mo for tirzepatide at any dose
  • Serves 46 states (all but Alaska, Hawaii, Louisiana and Mississippi)

What to weigh up

  • The 3- and 6-month tirzepatide plans stop at 7.5 mg a week; higher doses need a separate high-dose plan ($358–$450/mo)
  • Canceling stops future charges only: time already billed isn't pro-rated, and refunds are generally not available once your medical questionnaire is in
  • The semaglutide page also excludes Alabama

Regulatory note: the FDA issued a warning letter to Weightless Medical LLC dba WeightCare in February 2026. We still list and link to WeightCare; you should know the letter is on the public record before you decide.

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Allara HealthWeightCare
Normalized Cost/Month
Allara Health:
68/100
WeightCare:
48/100
Price Transparency
Allara Health:
72/100
WeightCare:
94/100
Nationwide Access
Allara Health:
78/100
WeightCare:
78/100
Formulation Options
Allara Health:
77/100
WeightCare:
66/100
Clinical Oversight
Allara Health:
77/100
WeightCare:
75/100
Contract Flexibility
Allara Health:
55/100
WeightCare:
77/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.